OTC · KALY
Kali, Inc.
$0.00$0.00 (0.0%)
Kali, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · GMVDF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
G Medical Innovations Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
G Medical Innovations Holdings Ltd’s next earnings report is currently expected on Mar 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow G Medical Innovations Holdings Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an intuitive medical device for measuring vital signs, which also incorporates electronic medical record functionality and adheres to clinical-grade reporting standards. Another offering is the Extended Holter Patch System, a multi-channel biosensor worn by patients that continuously records ECG data for up to two weeks. The company is also in the process of developing a Wireless Vital Signs Monitoring System, aiming to provide uninterrupted, real-time tracking of physiological parameters and biometrics. Furthermore, G Medical Innovations offers comprehensive monitoring services, encompassing both support for independent diagnostic testing facilities and personalized private monitoring solutions. Established in 2014, the company's corporate headquarters are located in Rehovot, Israel.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:05 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Kali, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (-3.7%)
ECGI Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 48.68% below the high.
$0.00$0.00 (0.0%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 99.5% below the high.
$0.00$0.00 (0.0%)
Microart Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Curative Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Amazonas Florestal, Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Acura Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.00$0.00 (0.0%)
GeneLink, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
